• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Adaptive TCR

edit

Adaptive TCR Corporation’s platform technology breaks open the field of genomics immunology. T-cell receptor profiling using Adaptive’s proprietary technology and software allows scientists to study the adaptive immune system to an unprecedented depth via high-throughput T-Cell Receptor (TCR) sequencing. Adaptive provides T-cell receptor profiling as a service to the research community.

The Adaptive team is developing a myriad of applications based on this technology, such as the study of immune system reconstitution post-bone marrow transplantation and the efficacy of vaccines in development. Adaptive is pioneering work using this technology to discover diagnostics in immune system disorders, such as Multiple Sclerosis and Type I Diabetes.

Recent Milestones

edit

• 
  Adaptive TCR received $5.8M in Series B funding. (6/10/11)
  Posted 6/10/11 at 6:44pm via finsmes.com
• 
  Adaptive TCR received $4.55M in Series A funding. (3/26/10)
  Posted 3/26/10 at 8:53pm via fiercebiotech.com
• 
  Adaptive TCR added Chad Robins as President & CEO.
  Posted 3/26/10 at 8:53pm
• 
  Adaptive TCR added Jessica Andriesen as Vice President of Operations.
  Posted 3/26/10 at 8:53pm

Videos

Screenshots

edit

Sources

1. Adaptive TCR grabs $4.5M in funding (fiercebiotech.com) [edit]
2. Adaptive TCR Completes $5.8M Series B Funding (finsmes.com) [edit]